News related to
Part

MrBeast is set to expand into telecommunications by launching a mobile phone service built using existing carrier networks, positioning himself as a mobile virtual network operator. According to investor materials seen by Business Insider, the YouTube star and his company plan to partner with carriers such as AT&T, T‑Mobile or Verizon, rather than constructing costly infrastructure. The business model mirrors that of Mint Mobile, where Ryan Reynolds […]

Yunfeng Financial Group, a Hong Kong‑listed firm with ties to Alibaba’s Jack Ma, has acquired 10,000 ETH—valued at approximately $44 million—using its own cash reserves. The firm intends to list Ether as an investment on its balance sheet as part of a strategic shift towards blockchain-enabled finance.

Yunfeng’s move aligns with its broader blueprint unveiled in July, which sets Web3 technologies, real-world asset tokenisation and artificial intelligence at the heart of its expansion strategy. The company emphasises that including Ether among its strategic reserve assets supports tokenisation efforts and integrates its financial operations with Web3 infrastructure. The firm also plans to explore Ethereum’s uses in insurance services and decentralised finance applications, signalling ambitions beyond treasury diversification.

This step places Yunfeng alongside a growing list of publicly traded firms embracing Ether as a reserve asset. Notable peers include SharpLink Gaming, BitMine Immersion Technologies and Ether Machine, which collectively reflect a broader institutional enthusiasm for Ethereum amid increasing corporate treasury adoption. The trend echoes earlier Fortune 500 strategies for Bitcoin, with Ethereum emerging as a comparable asset in this evolving corporate playbook.

Ether’s market resilience underpins Yunfeng’s strategy. Despite subdued crypto market conditions, ETH continues to trade above the psychologically significant $4,000 threshold, noted by analysts as a key marker of investor confidence. Technical analysis by market watchers, including the chartist CryptoGoos, suggests ETH is maintaining an upward breakout trend from a falling wedge formation, with potential upside targets stretching to $6,000—driven by heightened institutional inflows.

Yunfeng’s approach signals a calculated embrace of digital assets that transcends short‑term speculation. By positioning Ethereum at the foundational level of its Web3 and AI strategy, the company is asserting the utility of the token within financial services, as well as its role as a long‑term reserve option. Ether holdings will offer an alternative to traditional fiat reliance while granting greater operational flexibility across emerging business lines.

Only one-third of insurers in China provide mental health services, despite rising demand Fifty percent of insurers see personalisation as key to the success of health and wellbeing programs SINGAPORE – Media OutReach Newswire – 3 September 2025 – Aon plc (NYSE: AON), a leading global professional services firm, released insights from its inaugural 2025 Insurer Wellbeing Benchmarking Report offering a comprehensive analysis of the health and […]

Pharmaceutical developers are making headway with artificial intelligence tools to model drug absorption, distribution, and toxicity in human-relevant systems. This shift supports the U. S. Food and Drug Administration’s initiative to make animal testing an exception rather than a rule, particularly in pre‑clinical safety assessments for monoclonal antibody therapies and other drugs.

Regulatory authorities expect New Approach Methodologies—including AI-driven computational models, human-cell‑based systems like organs‑on‑chips, and organoids—to halve both development time and costs within the next three to five years. Recursion Pharmaceuticals recently advanced a cancer drug candidate to clinical trials in just 18 months, markedly faster than the 42‑month industry average.

The FDA’s April roadmap encourages drug developers to submit safety data from NAMs in Investigational New Drug applications. Firms providing robust NAM evidence may receive streamlined review processes—a concrete incentive to adopt these modern methods. A pilot programme allows select monoclonal antibody developers to use primarily non‑animal testing strategies, with results shaping future guidance.

Industry leaders at Charles River, Certara, Schrodinger, Recursion and InSphero are investing heavily in these emerging tools. Charles River’s NAM portfolio now generates roughly US $200 million annually. Certara’s president, Patrick Smith, stated the company is reaching a point where animal testing may no longer be necessary. Schrodinger utilises physics‑based simulations with AI to predict potential toxicity, while InSphero tests safety and efficacy using 3D liver microtissue models.

This transition builds on milestones such as the FDA Modernization Act 2.0, which removed the default requirement for animal data in drug development and formally recognised in vitro, in silico, and organ‑based methods as valid non‑clinical evidence. The Act is part of a broader regulatory overhaul that began with the ISTAND programme—for qualifying organ-on-chip tools—and continued with acceptance of the first liver‑chip into that pathway in 2024. Additional momentum comes from shifts in funding and policy: the NIH now prioritises human‑based models and no longer supports animal‑only proposals; the U. S. Navy has ended cat and dog experiments; and a federal push is underway to align academic and industry research with NAMs adoption.

Beyond regulation, academic research underscores the promise of computational approaches. A June 2025 study highlights AI and deep learning as enablers of predictive frameworks for vaccine and immunotherapeutic design—pointing toward a future where animal testing is replaced by computational models that refine vaccine targets and immune response predictions.

In parallel, the FDA is advancing its broader modernisation agenda through pilot programmes aimed at accelerating drug review timelines. Commissioner Marty Makary has proposed a split‑submission process that allows early review of key data during clinical trials. Coupled with AI tools such as Elsa—used daily within the FDA to expedite data review—this approach is projected to compress approval times from 10–12 months to as little as one to two months in eligible cases.

Ethically, these developments carry weight. Animal testing has repeatedly fallen short in predicting human outcomes—about 90 per cent of drugs deemed safe in animals fail in humans. New methods rooted in human biology promise not just faster, cost‑efficient drug pipelines, but also greater relevance and reliability in safety assessments, while reducing ethical concerns.

Though a complete end to animal testing is not expected immediately, experts anticipate a hybrid landscape in the short term, with animal studies still used where necessary but significantly reduced in favour of AI and human‑based alternatives.

JIAXING, CHINA – Media OutReach Newswire – 1 September 2025 – On the morning of August 26, at the Tide-Watching Resort Park in Yanguan Ancient City – also known as the “Tides and Music Resort” – a large number of participants gathered to play African drums as they welcomed the surging Qiantang River tide. The event successfully set a new Guinness World Record for the “Most People […]

Nigeria has launched a bold initiative to position itself at the forefront of artificial intelligence on the African continent. The Government Leadership & AI Summit held in Abuja on 1 September brought together policymakers, private‑sector leaders and global tech executives. Minister of Communications, Innovation and Digital Economy, Dr Bosun Tijani, delivered a sharp keynote, warning of the widening productivity gap if Africa fails to collaborate on AI infrastructure and governance. “If […]

EU regulators have suspended the anticipated antitrust penalty against Google over its advertising technology practices, prioritising trade negotiations with the United States. A modest fine, expected after a four‑year investigation sparked by a complaint from the European Publishers Council, has been put on hold as the EU awaits a commitment from Washington to reduce tariffs on European car imports from 27.5 percent to 15 percent.3 sources familiar with the […]

Advertisements

Greenlogue/AP Dubai is gearing up to host the 11th World Green Economy Summit on 1–2 October 2025 at the Dubai World Trade Centre, where green finance will sit at the forefront of global climate discussions. Under the theme ‘Innovating for Impact: Accelerating the Future of the Green Economy’, the summit will convene policymakers, investors, business leaders, academics and innovators to mobilise capital toward equitable, sustainable growth. Organised […]

HONG KONG SAR – Media OutReach Newswire – 2 September 2025 – ZHUOYU Technology (ZYT), a leading advanced driver-assistance systems (ADAS) brand, officially announced its European debut at the (IAA Mobility 2025), opening on September 8, 2025. As a crucial step in its global strategy, ZYT will showcase its full-stack integrated hardware-software proprietary technologies, unveil business plans in Europe, and host technical salons under the theme “Intelligence […]

Pogocache, a new open‑source caching system built in C by Josh Baker—known for creating Tile38—has entered general availability, promising breakthrough performance and seamless integration across multiple protocols. According to benchmarks on AWS c8g.8xlarge hardware, Pogocache delivers around 3.14 million queries per second, leaving behind Memcache, Redis, Dragonfly, Valkey, and Garnet. This cache server distinguishes itself by supporting a range of existing communication standards—Memcache, Redis/Valkey, HTTP, and PostgreSQL wire […]

AI’s growing sophistication is pushing operational costs skywards, as developers and startups grapple with soaring token usage, escalating compute demands, and shifting business models. At the heart of the challenge lies a paradox: while the per‑token price of AI continues to decline, the number of tokens consumed for meaningful tasks has surged dramatically, especially where reasoning-intensive workflows dominate. Tasks once considered lightweight now demand tens or even […]

A team led by Khalil Ramadi at NYU Tandon and NYU Abu Dhabi has unveiled a swallowable, wireless capsule designed to emit light inside the gut, allowing nerve cells to be activated without surgery—a development poised to transform gastrointestinal research and therapy.

The capsule, known as ICOPS, represents a remarkable leap in non‑invasive bioengineering. It employs optogenetic technology, by which specific neurons are genetically modified to respond to light. Once the target cells become light‑sensitive, patients can ingest an LED‑equipped capsule that, when powered externally, delivers precise stimulation to regions of the gut. This allows researchers to observe and influence neuronal circuits involved in digestion with a level of control previously limited to invasive approaches.

ICOPS stands out for its battery‑free design. It receives power wirelessly via magnetic induction from an external transmitter, enabling a compact, rodent‑scale form factor suitable for testing in freely moving animals. Crafted entirely via in‑house 3D printing—micro‑LEDs and custom coils included—this capsule avoids more expensive and restrictive cleanroom fabrication techniques.

Early animal trials suggest ICOPS can target neural circuits governing critical physiological functions, offering potential new avenues for treating gut motility disorders such as gastroparesis, where the stomach fails to empty properly. Simultaneously, the ability to stimulate region‑specific neural activity may trigger metabolic and hormonal responses, hinting at applications in metabolic disease and eating disorder therapies.

ICOPS is part of a broader research portfolio pioneered by Ramadi. Earlier innovations include FLASH, an electroceutical capsule that delivers electrical stimulation to modulate hunger‑related hormones, and IMAG, which uses magnetic fields to track pill location through the gut.

Adoption of ICOPS could revolutionise how scientists study the gut’s ‘second brain’—a vast, complex neural network fundamental to bodily control but historically difficult to study in its natural state owing to the invasive nature of previous optogenetic techniques.

Materials innovation plays a central role in this advancement. By eliminating the battery and using magnetic induction, the capsule remains small and unobtrusive. Its 3D‑printed construction offers scalability, making further adaptation for varied experimental models feasible.

Looking ahead, the implications for human healthcare are significant. The precision offered by ICOPS could enable therapies targeting select neural circuits within the gut, offering fine‑tuned interventions far more sophisticated than current broad‑spectrum prokinetic or antikinetic drugs. Furthermore, the platform may evolve to provide electrical stimulation or even deliver drugs directly to targeted gut regions.

That said, the path to clinical use remains lengthy. At present, ICOPS has demonstrated efficacy in rodent models. Transition to human clinical trials may take a decade or more, as researchers must navigate regulatory approval, safety testing, and scalability concerns.

Still, the research has drawn attention across scientific and media outlets, from Gulf News dubbing it a “Light Pill” capable of unlocking gut‑brain secrets to technical summaries highlighting how light‑activated capsules are revolutionising understanding of gut‑brain interactions.

Behind the innovation is a multi‑disciplinary team including Mohammed Elsherif, Rawan Badr El‑Din, Zhansaya Makhambetova, Heba Naser, Rahul Singh, Keonghwan Oh, Revathi Sukesan, Maylis Boitet, and Sohmyung Ha, working together across divisions at NYU Abu Dhabi and NYU Tandon. The project has benefited from funding awarded by NYU Abu Dhabi and Tamkeen through the CENTMED research centre.

Rocket Lab has expanded its in‑house manufacturing strength by successfully incorporating Planetary Systems Corporation, a Maryland‑based specialist in satellite separation systems. The deal, announced on 15 November 2021 and concluded by December that year, involved $42 million in cash and 1.72 million shares of Rocket Lab stock, with an additional performance‑based stock earn‑out dependent on PSC’s performance through 2022 and 2023.

PSC, celebrated for its “Canisterized Satellite Dispenser” and Lightband separation systems, boasts a flawless 100 percent mission‑success record across more than 100 launches. Its hardware has served a broad spectrum of launch platforms—from Rocket Lab’s own Electron vehicles to those managed by SpaceX, United Launch Alliance, Northrop Grumman, and international agencies such as Arianespace, the Indian Space Research Organisation, and JAXA.

By bringing PSC into its fold, Rocket Lab enhances its vertically integrated Space Systems division, now including Photon satellite buses, Maxwell dispensers, reaction wheels, star trackers, solar solutions, flight software, and the newly added separation hardware. PSC will continue operations in Maryland under the leadership of Mike Whalen as CEO, with founder Walter Holemans remaining chief engineer.

Chunked behind this strategic move is Rocket Lab’s intent to streamline the satellite deployment value chain, offering customers a one‑stop solution—from launch services to the final separation of payloads in orbit. Founder and CEO Peter Beck noted that integrating PSC’s proven hardware “simplifies the journey to orbit” by aligning hardware, software, spacecraft, and launch into a seamless package.

Alongside the acquisition of Advanced Solutions, Inc. in October 2021, this move aligns with Rocket Lab’s broader objective to secure technology, talent, and production capacity internally, reducing external dependencies. Industry observers have characterised this as a deliberate backward integration effort. A participant in an online space‑industry discussion observed:

“It seems like they are reverse integrating into their supply chain… instead of paying for products, buy the company, make the products for yourself, and make the margin on selling to others.”

Operationally, the acquisition has borne tangible returns. In November 2022, Rocket Lab secured two contracts totalling $14 million to supply Lightband separation systems for the Space Development Agency’s Tranche 1 transport layer constellation, reinforcing its position in national security‑oriented space architecture. The Lightbands, inherited from PSC, now supply critical satellite deployments with demonstrated reliability in specialised environments.

Rocket Lab’s expanded suite of capabilities positions it advantageously within a market increasingly dominated by fully integrated space services providers. By combining its Electron launch vehicle, Photon spacecraft, separation hardware, and on‑orbit software offerings, the company provides end‑to‑end mission support—a compelling proposition for both commercial and government customers.

With growth in space demand showing no signs of abating, particularly in low-Earth orbit constellations and defence networks, consolidating key enabling technologies under one roof offers Rocket Lab both operational efficiencies and competitive edge. The PSC acquisition stands as a pivotal building block in that strategy.

Linkin Park have confirmed their return to Abu Dhabi with a performance at Etihad Arena, Yas Island, on Tuesday 20 January 2026—tickets open for Live Nation’s general sale at 12 pm Gulf Standard Time that day. Presales for Linkin Park Underground community members, including Legacy and Passport Plus members, begin on Monday 1 September, with Live Nation presales running from 2–4 September, ahead of the general public sale […]

The mortgage market in Dubai and the wider UAE has entered a new stage of maturity. Once dominated almost entirely by cash buyers, today’s property landscape is increasingly shaped by mortgage financing. The first quarter of 2025 recorded AED 33 billion in cash transactions versus AED 21 billion in financed purchases. This indicates a clear rise in mortgage penetration as more residents, families, and long-term investors choose […]

By T N Ashok NEW YORK: For the first time since 2018, Indian Prime Minister Narendra Modi landed in China in late August 2025, greeted warmly by President Xi Jinping for the annual Shanghai Cooperation Organisation (SCO) Summit. Alongside Russian President Vladimir Putin, the trio projected a striking image of solidarity—three leaders from the world’s […]

PLYMOUTH, MINNESOTA; CHICAGO, ILLINOIS; BONN, GERMANY – Newsaktuell – 2 September 2025 – The Seeding The Future Foundation (STF), the Institute of Food Technologists (IFT), and Welthungerhilfe (WHH) today announced the next chapter of the Seeding The Future Global Food System Challenge (GFSC). With the conclusion of its fourth cycle, operations will transition from IFT to WHH, an international leader in food systems transformation and the fight […]

Nvidia has acknowledged that its AI models do not instinctively grasp common sense—such as knowing that birds cannot fly backwards or that ice melts into water—and has adopted an unusual remedy: assembling human “teachers” to devise pop‑quiz questions that train the AI to understand physical reality more reliably. At the forefront of this initiative is Cosmos Reason, Nvidia’s vision‑language model engineered to reason using physical common‑sense. Developed […]

A succinct pledge to resolve their border differences and reinvigorate cooperation was exchanged between Chinese President Xi Jinping and Prime Minister Narendra Modi during a summit in Tianjin. The meeting, marking Modi’s first visit to China since the border clashes of 2020, signals a strategic effort to steady bilateral ties ahead of the meeting of regional leaders.

At the outset, Modi acknowledged that disengagement along the Line of Actual Control has created a peaceful environment, underlining that tranquility along the border is essential for bilateral development. He emphasised that relations have moved in “a meaningful direction” and stressed that both countries should pursue strategic autonomy without being viewed through the lens of a third country. Xi mirrored that sentiment, contending that border issues should not define China‑India relations. He urged a focus on economic growth and expressed a hope that their meeting would “further elevate” bilateral relations to a stable trajectory.

This diplomatic retreat from escalating tensions emerges amid broader geopolitical recalibrations. The summit, bringing together more than 20 non‑Western leaders, offered a stage for Xi to advocate a new global order more favourable to the Global South, challenging Western dominance. He proposed the creation of a SCO development bank, new financial mechanisms to reduce dependence on the US dollar, AI cooperation, and a lunar research partnership.

For his part, Putin welcomed the revival of “genuine multilateralism” through the SCO framework and lauded efforts toward building alternative Eurasian security structures. The visual solidarity among the three —occasionally dubbed the “anti‑Western bloc”— underscores their shared interest in countering US influence and economic pressure, including US‑imposed tariffs on India.

India’s engagement at Tianjin reflects a broader wave of diplomatic stepping stones: direct flights have resumed, the Kailash Mansarovar Yatra has been revived, and Indian pilgrims are again welcome in Tibet. These developments follow mutual agreements on border patrolling mechanisms and a gradual easing of visa and tourism restrictions.

While the tone between Xi and Modi was markedly conciliatory, analysts caution that underlying issues persist. The legacy of the 2020 deadly Galwan clash remains a psychological and strategic fault line. Mistrust endures, and there is no immediate indication of a comprehensive border settlement or legally binding roadmap toward de‑escalation.

The SCO’s Tianjin gathering is the largest of its kind in the organisation’s history, with Xi presiding and an array of Eurasian leaders in attendance. The event signifies a collective push toward regional cooperation and institutional alternatives to Western‑led institutions.

AstraZeneca is poised to reshape hypertension care with a novel oral therapy that has yielded striking reductions in systolic blood pressure among patients whose condition remained uncontrolled despite multiple medications. In the global BaxHTN Phase III trial, daily doses of baxdrostat achieved a placebo-adjusted drop in systolic readings of approximately 9.8 mmHg at 2 mg and 8.7 mmHg at 1 mg over 12 weeks. The 2 mg dose delivered even more impressive […]

Google has eliminated around 35 percent of managers overseeing small teams, opting to shift many into individual contributor roles in a decisive drive to flatten its organisational structure. Brian Welle, vice president of People Analytics and Performance, revealed during an all‑hands meeting that the company now has substantially fewer managers and direct reports compared to this time last year. The aim is to reduce bureaucracy and accelerate decision‑making […]

Canada is advancing its Arctic security and defence strategy by expanding collaborations with NATO’s newest members—Finland and Sweden. As the geopolitical landscape shifts, Ottawa is actively moving beyond traditional reliance on the United States to forge deeper military, industrial and technological ties with Nordic allies, reinforcing its sovereignty and resilience in the High North. The Honourable Anita Anand, Minister of Foreign Affairs, has formalised a Canada–Finland strategic […]

Alibaba cloud to dedicate its global capabilities to support Bosch’s technology stack Both intend to deepen collaboration in leveraging Alibaba’s AI strength to facilitate Bosch’s business innovations, such as smart cockpit Bosch to expand its e-commerce presence in Southeast Asia, Spain, and Latin America through Alibaba’s global platforms HANGZHOU, CHINA – Media OutReach Newswire – 2 September 2025 – Bosch, a leading global supplier of technology and […]

A colossal leap in infrastructure development is underway as OpenAI pursues the establishment of a data centre in India with a striking capacity of at least one gigawatt. The project, integral to its Stargate initiative, ushers in a new era of AI infrastructure expansion across Asia.

OpenAI is actively exploring partnerships with Indian firms to bring this gigawatt-scale facility to life, though the precise location and timeline remain unspecified. The effort aligns with its Stargate programme—an expansive, multibillion-dollar venture in collaboration with SoftBank, Oracle and MGX to develop next-generation AI infrastructure.

The planned facility stands among the largest of its kind in the region and may be formally introduced by OpenAI’s chief executive, Sam Altman, during his anticipated visit to India in September. OpenAI has already gained legal footing by registering as an entity in India and is gearing up to open its first office in New Delhi later in the year, reflecting the nation’s importance as the company’s second-largest market by user base.

Financial implications of such mega‑scale AI infrastructure are enormous. According to Jensen Huang, chief executive of Nvidia, constructing a singular gigawatt-class facility could cost around $50 billion—$35 billion directed towards Nvidia’s hardware and $15 billion for supplementary systems. OpenAI’s ambitions also include similar “AI super‑factories” in Abu Dhabi and across the United States, all under the banner of Stargate.

This enormous investment is forecast to have ripple effects across the global AI ecosystem. With Stargate estimated at up to $500 billion, it underscores OpenAI’s strategic ambition to lead in AI infrastructure and the mounting demand for AI-optimised processing capabilities. Nvidia, for example, projects AI infrastructure spending could soar to the $3‑4 trillion mark annually by 2030, bolstered by commitments like those under Stargate.

Locally, establishing such a facility in India can offer tangible advantages. A dedicated data centre promises to reduce latency for Indian users while satisfying regulatory demands for local data storage, a critical consideration for enterprise clients and government services. The endeavour complements OpenAI’s earlier move to enable local data residency for services such as ChatGPT Enterprise and its API offerings, aligning with India’s regulatory framework.

India’s data centre ecosystem is expanding rapidly. From an installed capacity of approximately 950 megawatts in 2024, projections currently estimate that figure to nearly double—approaching 2 gigawatts by 2026. However, even with such growth, the nation still accounts for just a fraction of global data centre capacity despite generating a significant portion of worldwide data streams. The arrival of a gigawatt-scale project like OpenAI’s would mark a profound increase in both capacity and technological capability.

Environmental sustainability and energy demands also emerge as critical considerations. Hyperscale data infrastructure requires vast power and cooling resources, raising pressing questions about energy sourcing, water usage, and ecological impact—matters India is progressively addressing through green data centre policies and incentives.

OpenAI’s move echoes broader trends among global tech giants expanding their Indian footprints. For instance, Reliance Industries is planning a three‑gigawatt data centre in Jamnagar; Microsoft, Amazon, and Google are investing heavily in cloud infrastructure; and India’s government continues to support initiatives through Digital India and localisation mandates.

VISHNU RAJA
RYO YAMADA
HITORI GOTOH
IKUYO KITA